DTC-Flow: a flow cytometry-based detection platform for characterizing bone marrow disseminated tumor cells in breast cancer.
Saved in:
| Title: | DTC-Flow: a flow cytometry-based detection platform for characterizing bone marrow disseminated tumor cells in breast cancer. |
|---|---|
| Authors: | Chislock EM; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.; Abramson Family Cancer Research Institute, Philadelphia, PA, USA.; Department of Cancer Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Pan TC; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.; Abramson Family Cancer Research Institute, Philadelphia, PA, USA.; Department of Cancer Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Pant D; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.; Abramson Family Cancer Research Institute, Philadelphia, PA, USA.; Department of Cancer Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Chen Y; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.; Abramson Family Cancer Research Institute, Philadelphia, PA, USA.; Department of Cancer Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Woodfield G; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.; Abramson Family Cancer Research Institute, Philadelphia, PA, USA.; Department of Cancer Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Graves J; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.; Abramson Family Cancer Research Institute, Philadelphia, PA, USA.; Department of Cancer Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Lawrence-Paul MR; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.; Abramson Family Cancer Research Institute, Philadelphia, PA, USA.; Department of Cancer Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Belka GK; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.; Abramson Family Cancer Research Institute, Philadelphia, PA, USA.; Department of Cancer Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Wang J; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.; Abramson Family Cancer Research Institute, Philadelphia, PA, USA.; Department of Cancer Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Bayne L; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.; Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Blanchard T; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.; Abramson Family Cancer Research Institute, Philadelphia, PA, USA.; Department of Cancer Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Smith M; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.; Abramson Family Cancer Research Institute, Philadelphia, PA, USA.; Department of Cancer Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Ji X; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.; Abramson Family Cancer Research Institute, Philadelphia, PA, USA.; Department of Cancer Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Shih NNC; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Soucier-Ernst D; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.; Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Goodman N; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.; Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Nivar I; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.; Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Goodspeed B; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.; Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., DeLuca S; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.; Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Ndicu J; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.; Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Clark C; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.; Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Langer M; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.; Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., William Stavropoulos S; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.; Department of Radiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., DeMuth W; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Morschauser A; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Murphy W; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Nayak A; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Feldman M; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Clark A; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA.; Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Yu L; BD Biosciences, San Jose, CA, USA., Judge K; BD Biosciences, San Jose, CA, USA., Bornheimer S; BD Biosciences, San Jose, CA, USA., Pletcher CH Jr; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Moore JS; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., DeMichele A; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA. angela.demichele@pennmedicine.upenn.edu.; Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. angela.demichele@pennmedicine.upenn.edu.; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. angela.demichele@pennmedicine.upenn.edu., Chodosh LA; Secondary Prevention through Surveillance and Intervention (2-PREVENT) Translational Center of Excellence, Philadelphia, PA, USA. chodosh@pennmedicine.upenn.edu.; Abramson Family Cancer Research Institute, Philadelphia, PA, USA. chodosh@pennmedicine.upenn.edu.; Department of Cancer Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. chodosh@pennmedicine.upenn.edu.; Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. chodosh@pennmedicine.upenn.edu. |
| Source: | NPJ breast cancer [NPJ Breast Cancer] 2025 Nov 24; Vol. 11 (1), pp. 139. Date of Electronic Publication: 2025 Nov 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
